SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Breakthrough Company????? Endovasc ENDV

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jacalyn Deaner who wrote (21)4/10/1999 6:43:00 PM
From: NY_Know   of 94
 
Management

David P. Summers, Ph.D., MBA, FACA, is the CEO and Chairman of the Board. Dr. Summers is a Fellow of the American College of Angiology and has over 30-year's work in medicine, including medical device and drug delivery development. He is inventor of several liposomal drug delivery systems and medical devices and is author of 20 patents and has eight patents pending. Dr. Summers founded American BioMed, Inc. (NASDAQ: ABMI) in 1984 and served as its President and CEO until 1995.

Danilo D. Lasic, Ph.D., Chief Scientific Officer, is an internationally known physical scientist specializing in liposomal and nanoparticle drug delivery. Formerly with Liposomal Technology, Inc. (now Sequus), he served as Senior Scientist where he led studies for theoretical understanding of long-circulating liposomes. Considered as one of the principal developers of the "Stealth Liposome," he was primarily active in the scale-up of the liposome-laden anti-cancer drug, doxorubicin. Dr. Lasic has published over 150 papers, co-authored a four-book series and authored a monograph, Liposomes: From Physics to Application (Elservier, 1993).

Gary R. Ball, B.A. is COO, VP of R&D, Treasurer and Director. Mr. Ball is degreed in Electrical and Mechanical Engineering with extensive experience in microprocessor technology and R&D. He is co-inventor of three U.S. patents and has 10-years experience in manufacturing, regulatory and clinical trials.

M. Dwight Cantrell, Controller, CFO and Director., is degreed in accounting and has 30 years experience in public accounting and as CFO of a major electrical contractor. Since 1987, he has served as a consultant to large Southwestern banks brokering or facilitating transactions of up to $100 million.

John G. Charles, Exec. VP and Director, is a medical technologist who develops early-stage companies specializing in marketing and exporting medical instrumentation and diagnostic products to laboratories. He spent 25 years in microscope, microtome and clinical chemistry systems sales management for American Optical and Warner Lambert.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext